Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

LABORATORY CORPORATION OF AMERICA HOLDINGS

Filed by KELLEY DRYE & WARREN LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
$110,000.00
Expenses
Not reported
Filing UUID
71784115-45bb-4c28-97ef-bafefb9a119e
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Healthcare issues related to clinical laboratories; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Section 71120 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to modifying cost sharing requirements for certain expansion individuals under the Medicaid program; H.R. 3514/S.1816, the Improving Seniors Timely Access to Care Act, provisions relating to prior authorization of services to Medicare Advantage beneficiaries; and Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development;

Literal federal measure citations: H.R. 1, H. Con. Res. 14, H.R. 3514, S.1816

TAX · Taxation/Internal Revenue Code

Sections 70301, 70302, 70412(b), and 70603 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to extension of bonus depreciation under Internal Revenue Code Section 168(k), immediate deductibility of domestic research and development expenses under Internal Revenue Code Section 174, individual deductibility of employer-funded tuition assistance under Internal Revenue Code Section 127, and executive compensation under Internal Revenue Code Section 162(m), respectively; Title VII, Subtitle A, Chapter 3, Subchapter B of such Act, provisions relating to treatment of tax credits and reporting simplification under international tax law and guidance; and federal policy relating to income tax rates for corporations and income tax deductibility of corporate state and local taxes

Literal federal measure citations: H.R. 1, H. Con. Res. 14

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.